ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 551 • 2017 ACR/ARHP Annual Meeting

    Comparison of Drug Tolerability and Discontinuation Reasons between 7 Biologics in Patients with Rheumatoid Arthritis -Results from Kansai Consortium for Well-Being of Rheumatic Disease Patients (ANSWER cohort)-

    Kosuke Ebina1, Makoto Hirao2, Motomu Hashimoto3, Moritoshi Furu4, Wataru Yamamoto5, Ryota Hara6, Takanori Fujimura6, Toru Hirano7, Shuzo Yoshida8, Koji Nagai8, Hideki Amuro9, Yonsu Son9, Akira Onishi10, Kengo Akashi11, Masaki Katayama12, Keiichi Yamamoto13 and Hideki Yoshikawa14, 1Orthopaedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan, 2Orthopaedic Surgery, Osaka University, Graduate School of Medicine, Suita, Japan, 3Department of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 4Graduate School of Medicine, Kyoto University, Kyoto, Japan, 5Kurashiki Sweet Hospital, Okayama, Japan, 6The Center for Rheumatic Diseases, Nara Medical University, Kashihara, Japan, 7Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, Suita, Japan, 8Osaka Medical College, Osaka, Japan, 9Kansai Medical University, Osaka, Japan, 10Kobe University Graduate School of Medicine, Kobe, Japan, 11Department of Rheumatology and Clinical Immnology, Kobe University Graduate School of Medicine, Kobe, Japan, 12Osaka Red Cross Hospital, Osaka, Japan, 13Osaka City University, Osaka, Japan, 14Department of Orthopedics, Osaka University Graduate School of Medicine, Suita Osaka, Japan

    Background/Purpose:  More than 4 years have passed since 7 biologics became available for patients with rheumatoid arthritis (RA) in Japan, still lack reliable evidence in…
  • Abstract Number: 552 • 2017 ACR/ARHP Annual Meeting

    Mast Cells Are Involved in the Pathogenesis of Sjögren  Syndrome By Inducing Tissue Fibrosis

    Shinjiro Kaieda1, Kyoko Fujimoto2, Masaki Okamoto3, Masaki Tominaga2, Tomoaki Hoshino4 and Hiroaki Ida5, 1Department of Medicine, *Division of Respirology, Neurology and Rheumatology, Kurume University School of Medicine, kurume, Japan, 2Kurume University School of Medicine, Kurume, Japan, 3Medicine, Kurume University School of Medicine, Kurume, Japan, 4Department of Medicine, Division of Respirology, Neurology and Rheumatology, Kurume University School of Medicine, Kurume, Japan, 5Respiorogy, Neurology and Rheumatology, Kurume University School of Medicine, Kurume, Japan

    Background/Purpose: Mast cells have been implicated in many immune-inflammatory disorders. They mediate a variety of inflammatory and fibrotic conditions, but their role in sialadenitis and…
  • Abstract Number: 553 • 2017 ACR/ARHP Annual Meeting

    Decreased Circulating CXCR3+CCR9+ Th Cells Coincides with Elevated Levels of Their Ligands CXCL10 and CCL25 in the Salivary Gland of Sjögren’s Syndrome Patients Which Synergistically Facilitate Th Cell Migration

    Sofie L.M. Blokland1,2, Maarten R. Hillen3,4, Stephan Meller5, Bernhard Homey5, Glennda Smithson6, Aike A. Kruize2, Timothy R.D.J. Radstake2,7 and Joel A.G. van Roon2,3, 1Rheumatology & Clinical Immunology/ Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 2Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 3Laboratory of Translational Immunology, UMC Utrecht, Utrecht, Netherlands, 4Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 5Department of Dermatology, University of Düsseldorf, Düsseldorf, Germany, 6Takeda Global Research & Development Center, Inc, Chicago, IL, 7Rheumatology and Clinical Immunology, Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands

    Background/Purpose: Primary Sjögren’s syndrome (pSS) is characterized by dryness and lymphocytic infiltration in the salivary glands. CXCR3+ T cells and ligands CXCL9/10/11 are known to…
  • Abstract Number: 554 • 2017 ACR/ARHP Annual Meeting

    Prognostic Significance of Double Positive Anti Ro/SS-a and La/SS-B Antibodies in Patients with Primary Sjogren’s Syndrome: Prospective Salivary Gland Ultrasound Study

    Sang Heon Lee1, Kyung-Ann Lee2 and Hae-Rim Kim3, 1Division of Rheumatology, Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea, Republic of (South), 2Department of Nuclear medicine, Konkuk University Medical center, seoul, Korea, Republic of (South), 3Division of Rheumatology, Department of Internal Medicine, Konkuk University Medical Center, Seoul, Korea, Republic of (South)

    Background/Purpose: The aim of the study was to assess the diagnostic value of salivary gland ultrasonography (SGUS) as a single test for the detection of…
  • Abstract Number: 555 • 2017 ACR/ARHP Annual Meeting

    The Corrected QT(QTc) Interval Is Associated with Myocardial Fibrosis in Primary  Sjögren Syndrome, Assessed By a Cardiac Magnetic Resonance Approach: A Prospective Pilot Study at a Single Center

    Atsuma Nishiwaki1, Hitomi Kobayashi1, Isamu Yokoe2, Yosuke Nagasawa3, Kaita Sugiyama3, Natsumi Ikumi4, Takamasa Nozaki3, Noboru Kitamura5 and Masami Takei5, 1Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan, 2Rheumatology, Kyoundo Hospital, Sasaki Institute, Tokyo, Japan, 3Nihon University School of Medicine, Tokyo, Japan, 4St. Vincent's University Hospital, Department of Rheumatology, Dublin, Ireland, 5Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan

    Background/Purpose: Congenital heart block in the fetus and neonate, which can cause acquired QT prolongation, may be associated with maternal anti-SS-A/anti-SS-B autoantibodies. However, there are…
  • Abstract Number: 556 • 2017 ACR/ARHP Annual Meeting

    Identification and Validation of S100 Salivary Proteins As Putative Biomarkers for Different  Subsets of Primary Sjögren’s Syndrome Patients

    Chiara Baldini1, Francesco Ferro2, Nadia Ucciferri3, Enza Polizzi2, Silvia Rocchiccioli3, Marta Mosca2 and Antonella Cecchettini3, 1Internal Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy, 2Rheumatology Unit, University of Pisa, Pisa, Italy, 3IFC, CNR, Pisa, Italy

    Background/Purpose: S100 A proteins are multifunctional proteins expressed predominantly by myeloid cells, with a regulatory role in a variety of cellular processes including inflammation. Recently,…
  • Abstract Number: 557 • 2017 ACR/ARHP Annual Meeting

    Enhanced Expression of NLRP3 Inflammasome-Related Inflammation in Peripheral Blood Mononuclear Cells in Sjögren’s Syndrome

    Seong-Kyu Kim1, Jung-Yoon Choe2, Sung-Hoon Park3 and Hwajeong Lee2, 1Rheumatology, Catholic University of Daegu School of Medicine, Daegu, Korea, Republic of (South), 2Catholic University of Daegu School of Medicine, Daegu, Korea, Republic of (South), 3Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, Korea, Republic of (South)

    Background/Purpose: Sjögren's syndrome is a systemic autoimmune disease characterized by lymphocyte infiltration and subsequent dysfunction of exocrine glands, finally leading to dryness in the exocrine…
  • Abstract Number: 558 • 2017 ACR/ARHP Annual Meeting

    Salivary Syndecan-1 Levels Are Associated with Salivary Gland Dysfunction and Immune Dysregulation in Patients with Sjögren’s Syndrome

    Eon Jeong Nam1, Jong Wan Kang1, Jung Su Eun1, Na Ri Kim1, Sang Jin Lee1, Keum Hee Sa2, Gi Bum Bae3 and Young Mo Kang4, 1Division of Rheumatology, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea, Republic of (South), 2Division of Rheumatology, Department of Internal Medicine, Kyungpook National University, Daegu, Korea, Republic of (South), 3Division of Rheumatology, Department of Internal Medicine, Daegu, Korea, Republic of (South), 4Division of Rheumatology, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Republic of Korea, Daegu, Korea, Republic of (South)

    Background/Purpose: Sjögren’s syndrome (SJS) is a chronic autoimmune disorder with lymphocytic infiltration of exocrine and non-exocrine epithelia, in which epithelial cells play a critical role…
  • Abstract Number: 559 • 2017 ACR/ARHP Annual Meeting

    Performance of Multiple Platforms for Autoantibody Testing in Sjogren’s Syndrome

    Astrid Rasmussen1, Kiely Grundahl2, Lida Radfar3, C. Erick Kaufman4, David M. Lewis5, Barbara M. Segal6, Nelson L. Rhodus7, Harini Bagavant1, Umesh Deshmukh8, Christopher J Lessard8, R. Hal Scofield1 and Kathy L. Sivils1, 1Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma CIty, OK, 3Department of Oral Diagnosis and Radiology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 4College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 5Department of Oral Pathology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 6Rheumatology, Hennepin County Medical Center, Minneapolis, MN, 7Department of Diagnostic and Biological Sciences, University of Minnesota School of Dentistry, Minneapolis, MN, 8Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: The research classification and clinical diagnosis of SjšgrenÕs syndrome (SS) relies heavily on the detection of autoantibodies against Ro/SSA and La/SSB, particularly in the…
  • Abstract Number: 560 • 2017 ACR/ARHP Annual Meeting

    Clinical Relevance of Serum Free Light Chain Level As Biomarker in Primary Sjögren′s Syndrome

    Gwenny M. Verstappen1, Johan Bijzet1, Jolien F. van Nimwegen1, Martha S. van Ginkel1, Arjan Vissink2, Hendrika Bootsma1 and Frans G.M. Kroese1, 1Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 2Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands

    Background/Purpose: During immunoglobulin synthesis in B-cells, kappa and lambda light chains are produced in excess compared to heavy chains, and the surplus of light chains…
  • Abstract Number: 561 • 2017 ACR/ARHP Annual Meeting

    Comprehensive Immuno-Phenotyping of Follicular Helper T Cell and B Cell Subpopulations in Primary Sjögren’s Syndrome

    Nida Meednu1, Cécile Seifert2, Jennifer Barnard3, Madhu Ramaswamy4, Jeffrey Riggs5, Alex Rosenberg6, Jamie Biear7, Gianluca Carlesso4, Ralf G. Thiele8, Andreea Coca9, Fanny Monneaux2, Helene Dumortier2, Jacques-Eric Gottenberg2 and Jennifer H. Anolik1, 1Medicine- Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, 2CNRS, Immunopathologie et Chimie Thérapeutique/Laboratory of Excellence Medalis, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France, 3Medicine-Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, 4MedImmune LLC, Gaithersburg, MD, 5Respiratory, Inflammation and Autoimmunity (RIA), MedImmune LLC, Gaithersburg, MD, 6Department of Microbiology and Informatics Institute, University of Alabama at Birmingham, Birmingham, AL, 7Rheumatology, University of Rochester Medical Center, Rochester, NY, 8Medicine, University of Rochester Medical Center, Rochester, NY, 9University of Rochester Medical Center, Rochester, NY

    Background/Purpose: Primary Sjögren’s syndrome (pSS) is a systemic autoimmune disease characterized by immune cell infiltration in the salivary glands resulting in ocular and oral dryness.…
  • Abstract Number: 562 • 2017 ACR/ARHP Annual Meeting

    Anti-Muscarinic Receptor 3 Antibodies – a Cross Reactive Result of Ro60 Immunization

    Syed M.S. Quadri1, Biji T Kurien2, Kristi A. Koelsch3 and R. Hal Scofield4, 1Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Okalahoma City, OK, 4Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: Sjogren’s syndrome (SS) is a chronic autoimmune inflammatory disease characterized by impaired function of salivary and lacrimal glands leading to dry mouth and dry…
  • Abstract Number: 563 • 2017 ACR/ARHP Annual Meeting

    The Effect of Non-Invasive Vagus Nerve Stimulation on Fatigue and Immune Responses in Patients with Primary Sjögren’s Syndrome

    Jessica Tarn1, Sarah Legg2, Sheryl Mitchell2, Bruce Simon3 and Wan-Fai Ng4, 1Institute of Cellular Medicine, Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle-Upon-Tyne, UK, Newcastle-Upon-Tyne, United Kingdom, 2Freeman Hospital, Newcastle upon Tyne, United Kingdom, 3electroCore Medical LLC, Basking Ridge, NJ, 4Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom

    Background/Purpose: Primary Sjšgren's syndrome (pSS) sufferers have rated chronic fatigue as the most important symptom needing improvement and the main contributing factor to the loss…
  • Abstract Number: 564 • 2017 ACR/ARHP Annual Meeting

    Molecular Identification of a Ro-Specific Salivary IgA Repertoire with Unique Clonal Signatures in Primary Sjogren’s Syndrome

    Jing Jing Wang1, Alexander Colella1, Tim Chataway2, R. Hal Scofield3 and Tom Gordon1,4, 1Immunology, Flinders University, Adelaide, Australia, 2Proteomic Facility, Flinders University, Adelaide, Australia, 3Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Immunology, SA Pathology, Adelaide, Australia

    Background/Purpose: Autoantibodies against 60-kD Ro (Ro60)/SSA have been detected in the saliva and serum of patients with primary Sjögren's syndrome (SS) by routine methods that…
  • Abstract Number: 565 • 2017 ACR/ARHP Annual Meeting

    Fatigue in Primary Sjögren’s Syndrome (pSS) Is Associated with Lower Levels of Proinflammatory Cytokines: A Validation Study

    Kristen Davies1, Kamran Mirza1, Jessica Tarn2, Nadia Howard Tripp3, Robert J. Moots4, Nagui Gendi5, Michele Bombardieri6, Costantino Pitzalis6, Nurhan Sutcliffe6, Simon Bowman7, Neil J. McHugh8, John McLaren9, Devesh Mewar10, David Coady11, Kirsten MacKay12, Susan Knight13, Monica Gupta14, Marian Regan15, Cathy Lawson16, Jacqueline Andrews17, Peter Lanyon18, Mohammed Akil19, Elizabeth Price20, Annie Cooper21, Frances Hall22, Theodoros Dimitroulas23, Gavin Clunie24, Saravanan Vadivelu25, Ian Giles26, Bhaskar Dasgupta27, Steve Young-Min28, Dennis Lendrem29,30 and Wan-Fai Ng2,31, 1Institute of Cellular Medicine, Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle-Upon-Tyne, UK, Newcastle-Upon-Tyne, United Kingdom, 2Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle-Upon-Tyne, UK, Newcastle-Upon-Tyne, United Kingdom, 3Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK, Newcastle-upon-Tyne, United Kingdom, 4University of Liverpool, Liverpool, UK, Liverpool, United Kingdom, 5Basildon and Thurrock University Hospital, Basildon, UK, Basildon, United Kingdom, 6Barts Health NHS Trust & Barts and the London School of Medicine & Dentistry, London, UK, London, United Kingdom, 7Department of Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK, Birmingham, United Kingdom, 8Royal National Hospital for Rheumatic Diseases, Bath, UK, Bath, United Kingdom, 9NHS Fife, Kirkcaldy, UK, Kirkcaldy, United Kingdom, 10Royal Liverpool University Hospital, Liverpool, UK, Liverpool, United Kingdom, 11Sunderland Royal Hospital, Sunderland, UK, Sunderland, United Kingdom, 12Torbay Hospital, Torquay, UK, Torquay, United Kingdom, 13Macclesfield General Hospital, Macclesfield, UK, macclesfield, United Kingdom, 14Gartnavel General Hospital, Glasgow, UK, Glasgow, United Kingdom, 15Royal Derby Hospital, Derby, UK, Derby, United Kingdom, 16Harrogate District Hospital, Harrogate, UK, Harrogate, United Kingdom, 17Leeds Teaching Hospitals NHS Trust, Leeds, UK, Leeds, United Kingdom, 18Nottingham University Hospitals NHS Trust, Nottingham, UK, Nottingham, United Kingdom, 19Royal Hallamshire Hospital, Sheffield, UK, Sheffield, United Kingdom, 20Great Western Hospital, Swindon, UK, Swindon, United Kingdom, 21Royal Hampshire County Hospital, Winchester, UK, Winchester, United Kingdom, 22Addenbrooke’s Hospital, Cambridge, UK, Cambridge, United Kingdom, 23Dudley Group of Hospitals NHS Foundation Trust, Dudley, UK, Dudley, United Kingdom, 24Ipswich Hospital NHS Trust, Ipswich, UK, Ipswich, United Kingdom, 25Queen Elizabeth Hospital, Gateshead, UK, Gateshead, United Kingdom, 26Centre for Rheumatology, University College London, Centre for Rheumatology, University College London, UK, London, United Kingdom, 27Rheumatology, Southend University Hospital NHS Foundation Trust, Southend, UK, Westcliff-on-Sea, United Kingdom, 28Queen Alexander Hospital, Portsmouth, UK, Portsmouth, United Kingdom, 29Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK, Newcastle, United Kingdom, 30Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle-Upon-Tyne, UK, Newcastle-upon-Tyne, United Kingdom, 31Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK, Newcastle-Upon-Tyne, United Kingdom

    Background/Purpose: Primary Sjögren’s syndrome (pSS) is a chronic autoimmune rheumatic disease causing various symptoms including dryness, fatigue and pain. Previous work by our group has…
  • « Previous Page
  • 1
  • …
  • 1422
  • 1423
  • 1424
  • 1425
  • 1426
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology